Retractable Technologies (RVP) Non-Current Assets (2010 - 2026)
Retractable Technologies' (RVP) quarterly Non-Current Assets came in at $77.6 million in Q1 2026, down 9.35% YoY from $85.6 million in Q1 2025, and down 2.4% on a QoQ basis from $79.5 million in Q4 2025.
Retractable Technologies (RVP) Non-Current Assets (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Non-Current Assets data on file, last reported at $77.6 million in Q1 2026.
- Quarterly Non-Current Assets fell 9.35% year-over-year to $77.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $323.6 million (down 8.16% YoY) and the FY2025 annual result came in at $79.5 million, down 9.04% from the prior year.
- Non-Current Assets slipped to $77.6 million in Q1 2026, from $79.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $108.8 million in Q3 2022 to a low of $77.6 million in Q1 2026.
- A 5-year average of $95.0 million and a median of $100.3 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 103.55% — and 2025, when it slipped 14.58%.
- Tracing RVP's Non-Current Assets over 5 years: stood at $106.9 million in 2022, then retreated by 4.52% to $102.0 million in 2023, then declined by 14.28% to $87.5 million in 2024, then declined by 9.04% to $79.5 million in 2025, then declined by 2.4% to $77.6 million in 2026.
- The last three Non-Current Assets figures came in at $77.6 million (Q1 2026), $79.5 million (Q4 2025), and $82.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Retractable Technologies | 21.84 Mn | -18.03 Mn | 190,852.00 | 75.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.64 Mn |
| Dec 31, 2025 | 79.55 Mn |
| Sep 30, 2025 | 82.31 Mn |
| Jun 30, 2025 | 84.09 Mn |
| Mar 31, 2025 | 85.65 Mn |
| Dec 31, 2024 | 87.45 Mn |
| Sep 30, 2024 | 89.05 Mn |
| Jun 30, 2024 | 90.18 Mn |
| Mar 31, 2024 | 100.26 Mn |
| Dec 31, 2023 | 102.02 Mn |
| Sep 30, 2023 | 103.72 Mn |
| Jun 30, 2023 | 104.21 Mn |
| Mar 31, 2023 | 105.14 Mn |
| Dec 31, 2022 | 106.86 Mn |
| Sep 30, 2022 | 108.80 Mn |
| Jun 30, 2022 | 106.34 Mn |
| Mar 31, 2022 | 101.00 Mn |
| Dec 31, 2021 | 101.80 Mn |
| Sep 30, 2021 | 89.78 Mn |
| Jun 30, 2021 | 79.80 Mn |